Biotin-labeled RNA pull-down and western blot analysis
This protocol is extracted from research article:
Functional roles of antisense enhancer RNA for promoting prostate cancer progression
Theranostics, Jan 1, 2021; DOI: 10.7150/thno.51931

Biotin-labeled RNAs were in vitro transcript using Biotin RNA Labeling Mix (Roche) and T7 polymerase (New England Biolabs). C4-2 cells cultured in androgen-depleted medium were lysed in modified Binding buffer (150 mM NaCl, 50 mM Tris-HCl pH7.5, 1% NP-40, 0.1% SDS and 1% protease inhibitor cocktails). Cell lysates were incubated with biotin-labelled RNAs and streptavidin beads at 4ºC for 12 h. The beads were washed in wash buffer (50 mM Tris, pH 7.4; 150 mM NaCl; 0.05% Nonidet P-40 (NP-40); 1 mM MgCl2) at 4°C six times. The samples were subjected to western blot analyses as described previously 31. Briefly, protein samples were denatured and subjected to SDS-polyacrylamide gel electrophoresis (SDS/PAGE), and were transferred to nitrocellulose membranes (Bio-Rad). The membranes were immunoblotted with specific primary antibodies, horseradish peroxidase-conjugated secondary antibodies, and visualized by SuperSignal West Pico Stable Peroxide Solution (Thermo Fisher).

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.